Patent Assignment
Reel/Frame 059912/0598
Change of Name
Recorded: 2022-05-09
Pages: 3
Assignor
INTEGRAL EARLY DISCOVERY, INC.
Executed: 2020-09-11
Assignee
VALO EARLY DISCOVERY, INC.
399 BOYLSTON STREET, SUITE 505, BOSTON, MASSACHUSETTS, 02116
Covered Property
(1)
Thienopyrimidinones as Ubiquitin-Specific Protease 7 Inhibitors
Application:
17/161,324 →
Publication:
US 2021/0292337
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger
Sep 8, 2021
From: VALO EARLY DISCOVERY, INC.
To: VALO HEALTH, INC.
Reel/Frame 057438/0025 →
Assignment of Assignor's Interest
May 9, 2022
From: IOANNIDIS, STEPHANOS; TALBOT, ADAM CHARLES; FOLLOWS, BRUCE; BUCKMELTER, ALEXANDRE JOSEPH
To: FORMA THERAPEUTICS, INC.
Reel/Frame 059871/0414 →
Assignment of Assignor's Interest
May 9, 2022
From: FORMA THERAPEUTICS, INC.
To: INTEGRAL EARLY DISCOVERY, INC.
Reel/Frame 059910/0955 →
Security Interest
Jul 6, 2023
From: VALO HEALTH, LLC; VALO HEALTH, INC.
To: FIRST-CITIZENS BANK & TRUST COMPANY, AS AGENT
Reel/Frame 064207/0957 →
Release of Security Interest
Oct 17, 2023
From: FIRST-CITIZENS BANK & TRUST COMPANY, AS AGENT
To: VALO HEALTH, INC.; VALO HEALTH, LLC
Reel/Frame 065255/0660 →